Author:
Mekov Evgeni V.,Petkov Rosen E.,Kostadinov Dimitar T.,Antonov Krasimir A.,Jelev Deian T.
Abstract
AbstractChronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence.
Reference52 articles.
1. International variation in the prevalence of COPD ( the BOLD study ) : a population - based prevalence study;Buist;Lancet,2007
2. The hepatopulmonary syndrome;Lange;Ann Intern Med,1995
3. Remodeling in asthma and chronic obstructive lung disease;Jeffery;Am Respir Crit Care Med,2001
4. High COPD prevalence in patients with liver disease;Minakata;Internal Medicine,2010
5. Polymyositis , pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection;Aisa;Intern Med,2001
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献